Citing a number of previous studies, researchers estimated that fear of needles affects 33%–63% of children and 14%–38% of adults, contributing to “negative experiences” with needle procedures (and healthcare as a whole) for patients, caregivers, and medical providers.
This Q&A resulted from a conversation PSQH had with Nancy Riffel, MSA, BSN, RN, the patient services manager for Covenant HealthCare, a 643-bed hospital in Saginaw, Michigan, that is the largest healthcare provider in the Great Lakes Bay Region.
Some of the quality measures driving the VBP calculations and determining reimbursement payments are hospital-acquired infection rates, patient experience scores, readmissions, mortality and complication rates, and efficiency. Although CMS’ actions reduced the burden on hospitals by offering a suspension of reporting while lessening the impact of the VBP program, this did not lessen the expectation for hospitals to provide quality care.
According to the Medical Group Management Association, 97% of medical group practices have experienced a negative financial impact directly or indirectly related to COVID-19. On average, these practices report a 55% decrease in revenue and a 60% decrease in patient volume since the start of the COVID-19 public health emergency.
During Phase 1 of recovery, provider organizations will focus on the following broad areas to begin to revive their revenue streams: elective procedures and surgeries, diagnostic imaging, oncology, population health, ambulatory care, and telemedicine.
With the help of decision support tools, clinicians can differentiate between vector-borne diseases during a season where more people are at risk. A decision support system uses two or more items of patient data to generate case-specific advice. In practical terms, the output of such systems is used to arrive at a specific diagnosis.
With healthcare workers and their loved ones at risk, provider organizations are looking for ways to leverage technology to keep their workers healthy while continuing to deliver essential healthcare services in their communities. Increasingly, they are looking in a familiar place—remote patient monitoring—but with a twist. Now, in some cases, those patients are also employees.
Many factors have contributed to the rise in maternal mortality, including the increase in complex comorbidities in expecting mothers such as diabetes, obesity, hypertension, and cardiac disease. There has also been disagreement on the best approach to manage maternal patients, from creating a single oxytocin checklist to detailing more complex processes for managing preeclampsia.
The following Q&A resulted from a conversation PSQH had with Stacy Pur, vice president of product development at Minneapolis-based VigiLanz, a company that provides real-time clinical surveillance systems for hospitals.
During the pandemic, the spotlight has turned to telehealth and its power to deliver healthcare while maintaining social distancing. But as the World Health Organization warns of a second peak of coronavirus cases in the United States and a second wave of COVID-19 later this year, healthcare leaders must consider: How do we apply the rear-view mirror lessons from the first wave of the pandemic to our virtual response to consumers’ healthcare needs during the second wave?